Abcam Plc 34.4% potential upside indicated by RBC Capital Markets

Abcam Plc with ticker (LON:ABC) now has a potential upside of 34.4% according to RBC Capital Markets.



RBC Capital Markets set a target price of 1,950 GBX for the company, which when compared to the Abcam Plc share price of 1,280 GBX at opening today (04/02/2022) indicates a potential upside of 34.4%. Trading has ranged between 1,200 (52 week low) and 1,760 (52 week high) with an average of 472,863 shares exchanging hands daily. The market capitalisation at the time of writing is £2,962,567,396.

Abcam plc is a global life sciences company. The Company is focused on identifying, developing and distributing reagents and tools which are required in the fields of life science research. The Company’s product offering includes portfolio of antibodies and related protein research tools that are fundamental to its customers’ research and experimental workflow. The Company’s product type includes primary antibodies, secondary antibodies, biochemicals, isotype controls, flow cytometry multi-color selector, kits, loading controls, lysates, peptides, proteins, slides, tags and cell markers. The Company’s products are used by researchers to study biological pathways, which is critical for scientific research, diagnostics and drug discovery. The Company serves scientists and researchers in academic institutions, research institutes and pharmaceutical, biotechnology and diagnostics companies.